Notifications
2015_06_01 Data Snapshot

Table 1.  Get Full Table

Barcode UUID Date Type Category Notes
TCGA-A3-3306-01A-02-1737-20 16211caa-d5f8-4c55-a3a4-be3355122480 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3307 7ac1d6c6-9ade-49af-8794-10b5b96b2b05 09/02/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-A3-3308-01A-03-1737-20 b838468b-dfd5-49d4-bd7e-e74266201951 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3311-01A-03-1737-20 462b80e9-9015-43b7-b847-2fe3fdd384ea 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3313-01A-03-1737-20 dfdab8aa-668a-4a3f-ab2d-af868ed4c820 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3316-01A-03-1737-20 6330a1ab-f8cf-41f3-8046-d46d307c2e34 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3317-01A-03-1737-20 e37059b2-7a6d-4240-88e5-e7f755a68e41 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3319-01A-03-1737-20 9e45d6b9-e09f-4b75-8946-332f7bc8034e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3320-01A-03-1737-20 e6f15260-dcb7-4c5a-af56-5f26049f1dd0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3322-01A-03-1737-20 b58f34a0-7cbd-4bba-b2a5-48da31285610 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3323-01A-03-1737-20 020726a9-b511-4129-9ad2-f1978efea06f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3324-01A-03-1737-20 93d63239-8ec0-41ec-881d-739a4cc09f83 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3325 9868ae73-3459-4aa6-b71a-39953cdbbe1a 11/10/2012 KIRC Synchronous malignancy Pt with synchronous SCC of the neck. No prior malignancy.
TCGA-A3-3326-01A-03-1737-20 f1a88434-8fc2-4c36-998b-ece89d2a0bfe 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3328 8d02978a-10cb-4bbf-8980-78aebe70bcd1 09/02/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-A3-3329 21eea125-1298-42d3-a50c-57d596e0420d 09/02/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-A3-3329 21eea125-1298-42d3-a50c-57d596e0420d 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated w/ radiation
TCGA-A3-3329-01A-02-1737-20 0dd97442-3dad-411c-af6a-cf4380df97af 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3331-01A-03-1737-20 02c85a94-cbff-4a74-95bf-282e6dfcc597 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3335-01A-02-1737-20 a49aaffa-7cff-4440-a7c8-77590c005403 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3336 4ca5ff6a-ace1-4349-b269-b8e3aae16785 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Patient with synchronous non-Hodgkins Lymphoma treated w/ R-CHOP prior to procurement of TCGA tumor
TCGA-A3-3336 4ca5ff6a-ace1-4349-b269-b8e3aae16785 11/10/2012 KIRC Synchronous malignancy Patient with synchronous non-Hodgkins Lymphoma treated w/ R-CHOP prior to procurement of TCGA tumor
TCGA-A3-3336-01A-02-1737-20 9220327b-238b-4d85-bc6c-8dc0cdc8ca78 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3343 d4815225-0ac0-4295-a70d-74162066c0bd 09/02/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-A3-3343 d4815225-0ac0-4295-a70d-74162066c0bd 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated w/hormone therapy
TCGA-A3-3346-01A-03-1737-20 da27c634-7826-42a3-8b86-3c2bf7372513 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3347-01A-03-1737-20 83476cd5-f19f-4b6d-b670-08d2d975f304 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3349-01A-03-1737-20 2216921f-4864-45cd-ab5d-dc4337d21e90 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3351-01A-03-1737-20 52f39dab-34d9-42e6-a3a1-cfdfa39f320e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3352-01A-02-1737-20 18c7d39f-1d22-41af-a242-9b85cd07e02f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3357-01A-03-1737-20 0a391787-d50b-4d9b-8645-3c4e16c2b014 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3358 8a575e00-5dc5-416d-a8f5-2cdfb8e62c31 10/31/2012 KIRC Prior malignancy Prior malignancy cervical cancer. No systemic chemotherapy or radiation.
TCGA-A3-3359 e4cc8898-d1d8-4f6d-b01c-04cd30f0cd8f 09/02/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-A3-3362-01A-03-1737-20 96a10a56-098d-4a6a-969f-2a192aa24c81 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3363-01A-03-1737-20 55544522-fc45-49a1-8383-46de7554eb7d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3365-01A-03-1737-20 d5f95d7f-2fde-49dd-9e17-b435d7f424dd 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3367-01A-03-1737-20 7859c03e-1ee8-4726-93c6-3956f7e2f661 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3370-01A-03-1737-20 d8677058-4115-4f4e-9ed1-47861df01165 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3372-01A-03-1737-20 6f6c93b1-1da4-4128-b35b-5278fb3f99dd 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3373-01A-03-1737-20 828193ea-5a4f-427b-b2c4-a6834b773afb 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3374-01A-03-1737-20 5a6b7298-ee72-4e78-bbf1-b41b6ccd59fa 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3376-01A-03-1737-20 ebb58b2a-a5fc-4b84-8c88-a99a0f6a5dfb 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3378-01A-03-1737-20 40a5b47c-745c-43cf-bacd-ea370eacacbc 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3380-01A-03-1737-20 7be83762-afd6-4792-8fa9-cedc578e1833 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3382-01A-03-1737-20 2dbba60a-dd51-4d2c-920c-bf5ad38eb109 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3383-01A-03-1737-20 c737b9b0-9ea0-40a7-bc59-435a0c22f5a4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3385-01A-03-1737-20 260f47d1-d278-48ea-af55-97a32e22782e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3387-01A-02-1737-20 92a71abf-59cc-4b5c-a6f8-1393abab9d80 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-AK-3425 1b3f2411-52cd-4482-bea2-95cf72020c6f 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated w/ systemic chemotherapy and radiation
TCGA-AK-3425 1b3f2411-52cd-4482-bea2-95cf72020c6f 12/08/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-AK-3427 97fee782-9aa3-41c7-8b7b-53c9c69bdabc 12/09/2010 KIRC Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-AK-3427-01A-03-1737-20 2622f6ce-247a-488f-b4e8-eccdde5db56e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-AK-3428-01A-03-1737-20 d0d1d58a-5211-4b3d-93e5-fee8f6f63067 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-AK-3429 b3a6acab-00ad-48b7-94c2-bd56b461b48f 09/09/2010 KIRC Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-AK-3430 503a9c0b-64b8-41b9-a44f-9cbff9cefbad 09/09/2010 KIRC Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-AK-3434-01A-03-1737-20 80536c57-4e47-4035-ba49-84acc2df41d8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-AK-3436 b2feca3f-8602-4a30-92bf-958ab2a2bd5d 09/09/2010 KIRC Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-AK-3436-01A-03-1737-20 6e271200-142c-4fd1-8442-12578955b50f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-AK-3444-01A-03-1737-20 85001b63-dbc9-4689-ba78-f70078d3554e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-AK-3447 d7abeadd-ca92-4e18-ae06-70baf9ce42e0 12/08/2010 KIRC Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-AK-3450 0709749f-a30a-4fdd-a409-d12be09a5899 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy L LUAD treated w/ locoregional radiation.
TCGA-AK-3450 0709749f-a30a-4fdd-a409-d12be09a5899 12/08/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-AK-3451 fa543627-9e3c-4af9-bb33-f0cdd9fbc9cc 09/09/2010 KIRC Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-AK-3451-01A-03-1737-20 9e5b7562-e854-4f4e-9f93-271a96f3ccc4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-AK-3454 28e9b6f9-ab6a-400b-a6a9-79095a443591 10/31/2012 KIRC Prior malignancy Prior malignancy R uteter. No systemic chemotherapy or radiation.
TCGA-AK-3455 2ed3296a-5b10-40d8-8af4-90dc031657cd 10/31/2012 KIRC Prior malignancy Prior malignancy R KIRC. No systemic chemotherapy or radiation.
TCGA-AK-3456-01A-03-1737-20 0e03b634-82a6-4ac8-a4a2-b333f09d020b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4688-01A-02-1738-20 cb0749ca-a4ef-449d-b8f2-16d85120ef28 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4690-01A-02-1738-20 fbc08dbb-8333-491c-88e5-38268568d9f7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4691-01A-02-1738-20 5a569c96-f06a-413f-a926-8351b2a5bb6b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4693-01A-02-1738-20 f0acb3f0-37bf-4a7b-bd8a-20d9a6c30568 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4694-01A-02-1738-20 0e99587f-0c9b-4c73-b3c3-33ec34ab9405 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4696-01A-02-1738-20 1f4528b1-44c0-459d-a71e-b3c11575b6f4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4697-01A-02-1738-20 b5f9435c-4113-452d-83fa-d3933030d015 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4698-01A-02-1738-20 2708cabe-63de-4322-be86-4d43341a33d9 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4699-01A-02-1738-20 4d068cd2-2a92-481a-b15f-c4244022ecb6 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4700-01A-11-1738-20 573a87f6-c909-48e0-adeb-ca1140b5b1cf 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4701-01A-02-1738-20 443a8905-c067-4f52-ac83-1628cbd52cbc 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4703-01A-02-1738-20 d062e018-3d7e-4d3a-a472-4b931556b2f4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4706-01A-02-1738-20 e5674c04-a488-4500-85fa-34c229238643 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4707 4cfe9a35-80f2-422b-82e8-8f4b12ded992 11/10/2012 KIRC Synchronous malignancy Pt with synchronous R KIRC.
TCGA-B0-4707-01A-02-1738-20 b99dd5cb-d6f4-4aa4-af26-e9be00f7073a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4710-01A-02-1738-20 d17296c0-c26c-4bce-94d2-7f1fd4ed1859 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4712 3f72d63f-ad48-4500-baf6-897b1d6dda7d 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer treated with radiation.
TCGA-B0-4712 3f72d63f-ad48-4500-baf6-897b1d6dda7d 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with radiation.
TCGA-B0-4712-01A-02-1738-20 9fa6e096-3a86-46fc-8192-76a6da505148 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4713-01A-02-1738-20 b23f6894-9d65-4858-8d8e-3b9be0ca8286 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4714-01A-02-1738-20 fde8c824-a5a7-457e-a27d-80ff256fd81d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4718-01A-02-1738-20 a53b0875-2277-4d35-84a8-a64fa95ce66c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4810-01A-21-1738-20 05bfb262-52c1-45ec-a753-d9dab9a1cd0c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4811-01A-21-1738-20 9e06873b-c18e-4ddd-a4a5-02b023de795b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4813-01A-21-1738-20 b2a570c4-1588-4c61-957f-400a569519df 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4814-01A-21-1738-20 3756b506-c18b-4f67-9cb4-89b666a032b6 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4815 ff127be4-631a-4e0e-a971-842f9eb6760e 10/31/2012 KIRC Prior malignancy Prior malignancy of the pituitary gland. No systemic chemotherapy or radiation.
TCGA-B0-4815-01A-21-1738-20 4ef1cb41-5101-4cec-8045-7a708cefe25b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4816-01A-21-1738-20 e3264f18-0d44-405e-9b06-88cd0300543c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4817-01A-21-1738-20 dee1cedb-ed34-4e09-aea1-31c728568fda 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4818-01A-21-1739-20 df8f15d9-53eb-4a6e-9d6c-d5ad3632c74e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4819-01A-21-1739-20 42303efd-7799-4403-bcca-83d0898202db 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4821-01A-21-1739-20 fd91748c-814d-4344-a7f2-0b45847b9a6c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4822-01A-21-1739-20 bba5d145-5f17-4a12-9c5e-2e30d68f8de7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4823-01A-03-1738-20 9ffe08a3-770e-402a-962b-d70162896daf 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4824-01A-21-1739-20 299066df-06c3-4755-b2ca-18b98688d127 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4827-01A-03-1738-20 c82c9e7b-5521-444b-9e3f-980a0535aa9f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4828-01A-21-1739-20 aa9fac41-26c9-4a79-a87e-1416d7f57fa2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4833-01A-21-1739-20 7fc6be37-c28f-4a96-b934-ecd53230f53a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4834-01A-21-1739-20 4a9f563d-fb73-436a-b97e-ed14a4153f22 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4836-01A-21-1739-20 5e3254fe-06a0-4b5a-b0c3-8d9d49c9b4ec 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4837-01A-21-1739-20 43c4af68-6cbf-43c2-b2b0-f8ba43f2aaa1 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4838-01A-21-1739-20 2ab1091c-44ae-4145-894e-10e81d0cb30a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4839-01A-21-1739-20 26549998-3cfb-4048-8a06-19b87fd6cbb1 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4841-01A-21-1739-20 1f0a861a-fbdf-4fae-b89e-dc9d2bd5d685 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4842-01A-03-1738-20 1f8995f5-9131-4b33-9d51-69e0c6e8be3f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4843-01A-21-1739-20 7752edc0-5347-46ce-9aeb-af55385f7f8a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4844-01A-21-1739-20 50c7cca0-c55f-4a42-bce0-1355516396f4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4845-01A-21-1739-20 176cd46e-bd51-45ef-9ec0-19ee3b1037a5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4846-01A-21-1739-20 dd697fe7-8590-4dba-8645-ce936c78ddc5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4847-01A-21-1739-20 73855aed-d517-4fea-bbb8-9ff9d88c240e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4848-01A-21-1739-20 a5c906ba-a476-4ae7-801e-daa9cb73b8b7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4849-01A-21-1739-20 b8358dc4-ec6f-4c3c-9efa-75147b1e96b6 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4852-01A-21-1739-20 7699bb69-0ed2-4036-97fe-044d373e75d3 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4945-01A-21-1739-20 aef7aed3-c951-423c-8cee-b8786e4c4821 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5075-01A-21-1740-20 4989b969-47a4-4514-9d62-8d24338d0375 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5077-01A-21-1740-20 90b38871-dbc1-428b-9b6c-10e4fe18c66a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5080-01A-21-1740-20 281ab0c4-c16f-4f86-89bc-d23923fde487 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5081-01A-21-1740-20 ae5eb149-05ce-41ee-a8a5-ad8e6cf5aea4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5084-01A-21-1740-20 4178e2f2-9adf-4551-83b7-f7ba199acf17 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5085-01A-21-1740-20 8d37d999-ebfb-4365-a52e-c07584eed65d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5088 0022478c-4dfd-4cbe-a05e-fb20310844e3 10/31/2012 KIRC Prior malignancy Prior malignancy malignant melanoma of the head/neck. No systemic chemotherapy or radiation.
TCGA-B0-5088-01A-21-1740-20 9a5d45e5-0212-401e-bfe9-f8ff9a11edc7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5092-01A-21-1740-20 7cadb19e-dd38-4e69-882c-2b2c55b3958f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5094-01A-21-1740-20 95e7b6b5-deaa-473f-a6c1-cc7d56c9190d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5095-01A-21-1740-20 110928d3-0030-46a3-9738-974ef410826a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5096-01A-03-1740-20 0dc02012-9bcf-4cee-a511-4882129191c9 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5097-01A-21-1740-20 3ae72181-156a-4cf5-a45a-4e8bcc7336f5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5098-01A-21-1740-20 86b78da6-19ca-4522-a7d9-783fab70a387 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5099-01A-21-1740-20 68c99534-d96c-4753-8d35-9cc26bcd67a0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5100-01A-21-1740-20 57edfd41-958c-4a27-adb7-6b0372d0fb57 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5102-01A-21-1740-20 e0bf77b4-3095-448a-9417-6f6032cb8fb5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5104-01A-21-1740-20 e6209d01-e80b-4cf3-b93c-b2880abe2239 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5106-01A-21-1740-20 463570d8-686a-4b07-8c1f-3eed11b64df6 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5107-01A-21-1740-20 200fc171-d93c-4045-b69d-450b7e8f5ed9 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5108-01A-21-1740-20 4b349bac-dda2-4ddf-9815-c2389d2cbcca 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5109-01A-03-1740-20 7fab4cfc-fea7-4624-9ce6-527f9aca8f60 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5110-01A-21-1740-20 8d3f47ca-373d-428e-8d24-ea0d697b516f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5113-01A-21-1740-20 f65735cf-72fb-490c-abe2-5973759d4ee5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5115-01A-21-1740-20 3e1e4309-097d-403e-83fd-ecd0c45e3c87 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5116-01A-03-1740-20 ccb762ad-c2fa-4138-80a5-fe3994d13651 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5117-01A-21-1740-20 46129b23-fa90-4c0d-9191-d9d26287c34b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5119-01A-03-1740-20 2e3b9519-3f98-4f5a-a75b-7e07cd3f7781 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5120-01A-21-1740-20 e466f011-79a1-4158-b796-f8e9dda32d68 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5121-01A-03-1740-20 b501ca20-c446-4f59-ac92-f32dce633a98 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5399-01A-21-1741-20 94e57906-e27c-4513-923a-e9a0cd709b2d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5400-01A-21-1741-20 94da797a-7440-4175-ad79-7eed8bd581d0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5402-01A-21-1741-20 ace6514d-5971-4e4d-8184-0c96f0e94d7f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5690-01A-13-1741-20 d91bf511-bcc4-4d74-8e6b-7306cb8c494b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5691 31a0dd95-8199-4d25-b40d-4b353644af46 10/31/2012 KIRC Prior malignancy Prior malignancy L LUAD. No systemic chemotherapy or radiation.
TCGA-B0-5691-01A-13-1741-20 356831cc-5707-453e-b580-25d762d95e3c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5692-01A-13-1741-20 30121cac-9b7b-4120-a045-e4a4f4e10749 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5693 db058eb4-9c5e-4226-92d1-de24aea83630 11/10/2012 KIRC Synchronous malignancy Pt with synchronous R KIRC.
TCGA-B0-5693-01A-13-1741-20 5aec168d-3a06-4266-89a4-e1cb201a746d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5694 11111b58-c7df-4291-ad8a-4baec9ff7d1f 11/10/2012 KIRC Synchronous malignancy Pt with synchronous bilateral LUSC.
TCGA-B0-5694-01A-13-1741-20 c89bea79-a7de-45c0-af36-028aa178d0ac 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5695 fb9bafa5-7133-4955-8156-4eb6763dc8e1 11/10/2012 KIRC Synchronous malignancy Pt with synchronous chronic lymphocyctic leukemia.
TCGA-B0-5695-01A-13-1741-20 ea556872-4e9c-42cf-a35a-cd004db2bb09 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5696-01A-13-1741-20 e505fa8c-61e2-489d-9477-4ecb118d83d8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5697-01A-13-1742-20 15296fb4-c486-458f-b91f-f5f75774ab35 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5698 d26f3a6b-72f4-4e48-815e-57b8b211112d 11/10/2012 KIRC Synchronous malignancy Pt with synchronous R LUSC.
TCGA-B0-5698-01A-13-1741-20 ceb765f5-5bec-4318-834c-c98c22487b50 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5699-01A-13-1741-20 7359cdec-10e0-4e85-9b8b-b8d158ba9d83 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5700-01A-13-1741-20 c5ed6049-225b-4f0c-8f17-a704a33a5c70 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5701-01A-13-1741-20 59b73057-8a42-42c6-917a-5d8946b7a7aa 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5702-01A-13-1741-20 0f2f2325-ee0d-450d-8e9c-2c10fe75abec 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5703-01A-13-1742-20 5dc97b12-b71e-43f8-a6b0-4344fef448ba 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5705-01A-13-1742-20 bf0b180b-cafe-49c0-a424-aa7a1bf8f438 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5706-01A-13-1742-20 d71ce946-fa69-4ef5-876e-98ca0b07528c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5707-01A-13-1742-20 064cd791-aa56-4b56-b052-e9eb5df76692 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5709-01A-13-1742-20 6ad14377-07e0-4d29-a047-dec57771f8ea 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5710-01A-13-1742-20 413cecd4-e92a-482e-b9e3-a6b202f53d5c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5711-01A-13-1742-20 7f78aa70-ce51-4103-a7cd-7158dfd0376c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5712-01A-13-1742-20 d4d925ec-9d9d-4bad-8528-3354bc5570c8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5713-01A-13-1742-20 6ad5107c-7c8e-4603-9179-39904d47b417 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5812 326745d8-98ca-4f4d-b217-96aea9faa1ad 11/10/2012 KIRC Synchronous malignancy Pt with synchronous L KIRC.
TCGA-B0-5812-01A-13-1742-20 533ca77c-49af-4517-816e-db70c9e59088 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-3923-01A-03-1737-20 9e136a54-511b-412d-ae6b-d9be6c8f53b0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-3924-01A-03-1737-20 af7a6247-4d5c-4b84-b528-60581fb506b7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-4098-01A-03-1737-20 a8a65f31-baa1-455f-b604-4fc27c9e5b8e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-4099-01A-11-1738-20 6acb0118-1b91-48a6-b5db-66a786c0e51e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-4101-01A-03-1737-20 23447bd7-4415-4b03-86a9-a89033837c84 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-4102-01A-03-1737-20 ba82eba0-3155-474b-80d4-e33d2f69b37b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-5633-01A-21-1741-20 2bb03c87-a6cd-4b3e-8ad9-700acfb67353 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-5635 597c81a3-5820-48b0-9a9c-c45257c7ad70 10/31/2012 KIRC Prior malignancy Prior malignancy skin cancer. No systemic chemotherapy or radiation.
TCGA-B2-5635-01A-21-1741-20 5fee0715-102e-4ba9-9d48-1acddc8a079b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-5636-01A-03-1741-20 5ee596e6-faa2-4622-8786-aeb769c01310 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-5639 73cb1350-7590-4f79-bb86-3f395466652e 01/24/2012 KIRC Neoadjuvant therapy [intgen.org]: Patient received palliative neo-adjuvant radiation to the field where tumor was located.
TCGA-B2-5639-01A-21-1741-20 4270d9bd-75a6-40c3-a900-dc5233d9794f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-5641-01A-21-1741-20 da2d6171-9d4a-47f3-9c0a-eae0d55a81a4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5377-01A-21-1741-20 8b618e44-ee89-4f9a-b6f2-1239cbd668b0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5378-01A-21-1741-20 5cc943a6-4192-43bb-9e3b-5dc198f87152 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5832-01A-13-1742-20 96c36e23-d573-4d7a-ba24-66d12687f8a2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5834-01A-13-1742-20 39d6d6d4-3d29-4a67-b560-ae8d0cc603d4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5835-01A-13-1742-20 f6c378eb-caa6-49b7-81c7-e82dac01ca35 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5836-01A-13-1742-20 9e9a511a-6ab0-492f-9fda-0c9aa2d9118d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5838-01A-13-1742-20 c0c58f6a-2e14-4ad5-b622-883a5341cc60 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5843-01A-13-1742-20 39f3e6a4-160e-4398-8d84-363f0a26aa91 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5844-01A-13-1742-20 4717e85e-e8fa-4772-9ee8-e088f1d53970 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-4143-01A-21-1738-20 de6aa790-f3d4-49d5-b3c6-64055a498cf7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-4146-01B-13-1738-20 123c39da-edb4-4e50-b4e9-3e3d903becec 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-4148 18325fdc-594b-4545-a77d-adb07a32ec73 05/28/2011 KIRC Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-B8-4153-01B-13-1738-20 d2de8a92-68dd-4d67-a0b1-421b9a9f2e50 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-4620-01A-03-1738-20 083bb823-89a5-46ee-9191-289301cf1f91 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-4621 65d56c51-1d58-419e-8c77-a037fc588f5b 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-B8-4621 65d56c51-1d58-419e-8c77-a037fc588f5b 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-B8-4621-01A-03-1738-20 961b9a19-83eb-4f29-8ab5-7ad11ed6c795 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-4622-01A-03-1738-20 30e2b06b-5f6e-4976-94d4-a2a6edbbe8b7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5158-01A-21-1740-20 41941de7-218b-4275-983c-ce73253e203c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5159-01A-21-1740-20 72f1e6e4-cef0-4264-b718-82d8be8245b5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5162 d62d39f9-c896-4758-a785-e236f0154f14 10/31/2012 KIRC Neoadjuvant therapy Prior malignancy R kidney and prostate, no systemic therapy or radiation. Neo-adjuvant sutent given for TCGA tumor.
TCGA-B8-5162 d62d39f9-c896-4758-a785-e236f0154f14 12/06/2010 KIRC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy / Subject was positive for neo-adjuvant therapy
TCGA-B8-5162-01A-21-1740-20 37894361-b6e8-403b-ae5b-61a680088fcb 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5163-01A-21-1740-20 4aeba2cd-ce47-4695-a684-f64c2e0bfe6f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5164-01A-21-1740-20 0d8fd09c-0213-45aa-94fc-4cfcf52d78cf 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5165-01A-21-1740-20 74a72bf2-d7e1-4fe1-b7ab-5b2939265e32 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5545-01A-03-1741-20 a90c3786-b227-4015-a1c1-03d6401806a2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5546-01A-21-1741-20 f144f7ce-fa15-4632-a0bd-2d93bf4fedcf 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5549-01A-21-1741-20 7da3accf-78b5-4111-b2f3-974b90de0f7d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5550-01A-21-1741-20 cf353041-af01-46f3-be8b-2c53079cd59d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5551-01A-21-1741-20 436a8460-d131-4e31-a9c5-a2a66294180c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5552-01B-21-1741-20 000378c1-cd16-45c9-bcfa-e65eae6e9700 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5553-01A-21-1741-20 ff25ff21-80d0-419d-9306-fd04a43942a5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-A54K a2663a86-a006-4867-9e88-2b523df48303 06/16/2014 KIRC History of unacceptable prior treatment related to a prior/other malignancy BCG given to prior bladder cancer
TCGA-BP-4158 1cdb170b-9765-45ee-9e3e-388d0a419746 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated w/ hormones cancersodex, lupron and radiation
TCGA-BP-4158 1cdb170b-9765-45ee-9e3e-388d0a419746 11/22/2010 KIRC Prior malignancy IGC new notifications of 11/10/2010
TCGA-BP-4158-01A-03-1737-20 af5781bd-6cdc-4ddd-99c7-30fd4c0c2de1 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4160 844d8b94-59b0-4787-97eb-474e3aa3e022 11/10/2012 KIRC Synchronous malignancy Prior malignancy prostate cancer treated w/ lupron. Synchronous R kidney cancer
TCGA-BP-4160 844d8b94-59b0-4787-97eb-474e3aa3e022 12/06/2010 KIRC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy
TCGA-BP-4161-01A-03-1737-20 674b43f4-04f8-4354-a0de-458ce273aff9 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4164 ba96288c-60d3-4e56-8940-90c5b22d4ddc 11/10/2012 KIRC Synchronous malignancy Pt with synchronous R KIRC.
TCGA-BP-4164-01A-03-1737-20 f27b21a6-aa99-4a38-af7f-f89b6e66e65e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4165-01A-03-1737-20 040ed845-22bf-455f-b908-6da8c20616b7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4169-01A-03-1737-20 af490ade-1a4d-4275-90f7-5aaa226c29fc 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4170-01A-03-1737-20 7d5fd2fb-0e1b-46fc-a93e-9e53e435a9a3 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4173-01A-03-1737-20 9cd3fc5f-398b-4023-bcd5-c201418b2c64 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4174-01A-03-1737-20 adf85281-7341-482f-a266-20497cdbdc1b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4325-01A-03-1737-20 8b3caafa-8af4-4d18-bf96-b78e278ee09c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4326-01A-03-1737-20 c7272a60-9daa-4a1c-bd36-587546b70c8f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4327 9b84d013-713b-4571-888c-12863fdd4a52 10/31/2012 KIRC Prior malignancy Prior malignancy colon cancer. No systemic chemotherapy or radiation.
TCGA-BP-4327-01A-03-1737-20 26511831-95bc-4abe-b4a5-8b21bcf0ef91 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4329-01A-03-1737-20 9011ac4c-2499-4c39-a579-6ee216704824 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4330-01A-03-1737-20 dcad5dbd-c88e-4651-b454-9c14e1db7183 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4331 39867756-0ef0-4408-a0e1-c85ae7adb8ee 04/02/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4331 39867756-0ef0-4408-a0e1-c85ae7adb8ee 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy squamous cell carcinoma of anus treated w/ 5-FU and mitomycin and locoregional radiation. Synchronous malig. of R kidney.
TCGA-BP-4331 39867756-0ef0-4408-a0e1-c85ae7adb8ee 11/10/2012 KIRC Synchronous malignancy Prior malignancy squamous cell carcinoma of anus treated w/ 5-FU and mitomycin and locoregional radiation. Synchronous malignancy of R KIRP.
TCGA-BP-4331-01A-03-1737-20 ef1c227c-4d03-4e25-a1a9-0cd0b231d1e7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4332-01A-03-1737-20 247045c4-617c-40f8-8395-2f0786eb031c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4334 e5eca191-f585-490d-81e3-9cced1047093 06/21/2011 KIRC Item in special subset Subsequent to most TCGA analysis, TSS noted that the case may be Chromophobe Renal Cell Carcinoma. Program Office determined this will be a Notification vs. a Redaction
TCGA-BP-4334-01A-03-1737-20 94399481-973f-4c06-80d2-accae70b17a4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4335-01A-03-1737-20 434984d0-d236-4bc4-813b-bd3dd729c555 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4337-01A-03-1737-20 224d6226-a93c-45be-851f-e132873d392a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4338-01A-03-1737-20 75f0afa0-c95a-4278-bd18-b35c0c8b2f17 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4341-01A-03-1737-20 d694f377-86b7-47fd-a3e8-18017f3ee718 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4342 c0e26587-3191-4396-a20b-da9e7de213f4 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy bladder cancer treated w/cisplatin, 5-FU, and radiation.
TCGA-BP-4342 c0e26587-3191-4396-a20b-da9e7de213f4 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4342-01A-03-1737-20 60705414-813c-498c-bf3c-97c40db3478a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4343-01A-03-1737-20 04650bc4-e8d0-480d-b1eb-b4275b120f94 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4344 513a4de3-427d-4823-8644-b6faf69a137f 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy bladder cancer treated w/ mitomycin. Prior malignancy uterine cancer. No systemic chemotherapy or radiation.
TCGA-BP-4344 513a4de3-427d-4823-8644-b6faf69a137f 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4344-01A-03-1737-20 11d61a68-5ddf-43c9-a336-1a40ae080109 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4345-01A-03-1737-20 b51f444b-51a0-4901-a42d-286e0819323f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4346-01A-03-1737-20 28206fd9-253b-4f2b-94f1-1e558edd32ed 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4347-01A-03-1737-20 63348de4-1e61-4000-95b6-b43b937f7945 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4349-01A-03-1737-20 17e49511-4cef-48c8-8ee3-27dabaca0ce1 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4351-01A-03-1737-20 a0748d1b-a752-4718-900e-31c703790ae1 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4352-01A-03-1737-20 3aebcb7d-ac9f-44b1-b9ab-bebd4e09ebc7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4353 f9e6afeb-cf13-4dd7-8a1f-571ab610df4f 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy lymphoma of L groin treated w/ systemic chemotherapy.
TCGA-BP-4353 f9e6afeb-cf13-4dd7-8a1f-571ab610df4f 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4353-01A-03-1737-20 bbba53ef-e89f-44b9-b099-492dd3670186 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4354 d9208e7b-0b47-43ff-a4e8-d4e591e286c4 11/10/2012 KIRC Neoadjuvant therapy Patient received neo-adjuvant gefinitib and sunitinib for tumor submitted to TCGA.
TCGA-BP-4354 d9208e7b-0b47-43ff-a4e8-d4e591e286c4 12/19/2010 KIRC Neoadjuvant therapy [intgen.org]: Subject Positive for Neo-Adjuvant Therapy
TCGA-BP-4354-01A-03-1737-20 10f73a76-335a-4453-bacb-9583e6023dc2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4355-01A-03-1738-20 960d0a23-8e93-4d10-88dc-fcd6f658e706 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4756-01A-21-1738-20 8c67e316-4e1d-4874-a55b-7f9bd4bf3b13 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4758-01A-21-1738-20 aa669d52-98ba-42d3-93e8-787733bc7c0b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4759-01A-21-1738-20 31e6ba1f-29b1-4063-9de4-e0adf88f344d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4760 4cfe4f31-f62c-423a-8b9f-17f455b15313 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer treated with locoregional radiation. Patient with synchronous malignancy of R KIRC.
TCGA-BP-4760 4cfe4f31-f62c-423a-8b9f-17f455b15313 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with locoregional radiation. Patient with synchronous malignancy of R KIRC.
TCGA-BP-4760 4cfe4f31-f62c-423a-8b9f-17f455b15313 11/10/2012 KIRC Synchronous malignancy Prior malignancy prostate cancer treated with locoregional radiation. Patient with synchronous malignancy of R KIRC.
TCGA-BP-4760-01A-03-1738-20 20eede14-8679-4d83-81f9-9c1d5b950a88 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4761-01A-21-1738-20 ce230c92-748e-4040-8991-627700208b33 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4762 2dde6b93-11a8-424f-9b54-b1a81cd26895 10/31/2012 KIRC Prior malignancy Prior malignancy cancer R shoulder. Prior malignancy Leiomyoscarcoma R leg. No systemic chemotherapy or radiation for either.
TCGA-BP-4762-01A-11-1738-20 bd940189-3a7b-44ba-a659-fdde384a3274 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4763-01A-21-1738-20 f5100193-9a50-444c-beae-7576c0c0453c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4765-01A-21-1738-20 40882c39-369a-4e03-91c2-249b7281322c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4766-01A-21-1738-20 99f6d631-e005-4d8d-a1ae-989af4754b2e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4768-01A-21-1738-20 96cb4d2d-609e-4b1e-9419-131610ca437a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4769-01A-21-1738-20 b4a61eb2-266d-4045-a9a6-7365abee5431 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4770-01A-21-1738-20 9c83aa7c-d798-4563-9714-1884fbb56ad2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4771 31201e73-a922-4acd-b859-fa2f9ba0af93 05/18/2015 KIRC Neoadjuvant therapy Per the TSS, the patient had prior chemotherapy (but no additional info given). Also the patient had radiation (external beam) 2 months prior to the TCGA cancer procurement.
TCGA-BP-4771-01A-21-1738-20 4c226272-8648-40c6-8a8d-573345c19516 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4774-01A-21-1738-20 efc103d5-d048-4e41-a473-c4775d725115 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4775 c22d25c2-b836-4b91-8f4f-2062be002232 10/31/2012 KIRC Prior malignancy Prior malignancy DLBCL of the stomach. No systemic chemotherapy or radiation.
TCGA-BP-4775-01A-21-1738-20 13da54ae-88a6-42d7-b949-a872cfad9573 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4776-01A-21-1738-20 f9bdec2c-d3a1-403c-a192-9e782100b645 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4777-01A-21-1738-20 3d99a806-eab0-43c9-9a71-34150484e91e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4781-01A-21-1738-20 d8780152-4117-4036-a86e-e34b1627fa0a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4782 9a404208-c3d3-4e6b-b511-1a4ccf595c18 11/10/2012 KIRC Synchronous malignancy Pt with synchronous R KIRC.
TCGA-BP-4784-01A-21-1738-20 f73d0fb0-8ed0-4803-888a-3ded7c53fdde 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4787-01A-21-1738-20 6c005cf1-c892-41a9-8e96-94fddc1bbe8f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4789-01A-21-1738-20 a5959caf-f793-48d1-ae2b-99bbe598089d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4790-01A-21-1738-20 f68d3386-1a3f-4856-ac90-4d38ce302dcb 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4795 38469030-8539-4c76-b53b-57073569501c 10/31/2012 KIRC Prior malignancy Prior malignancy thyroid cancer. No systemic chemotherapy or radiation.
TCGA-BP-4797-01A-21-1738-20 2cbc04e7-27a6-494b-a94e-33d8160ffec2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4798-01A-21-1738-20 84ad006d-8482-45eb-978a-81b49604f39a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4799 e719b7f3-27c4-4017-9d34-a660776c2cd7 11/10/2012 KIRC Synchronous malignancy Pt with synchronous follicular lymphoma.
TCGA-BP-4799-01A-21-1738-20 c39ac284-5ce3-494c-9f49-15914eecb7f3 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4801-01A-03-1738-20 f1c4c218-0bd0-4b20-9031-7df555ca2b07 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4803-01A-21-1739-20 653c3f46-d3b2-4b04-b71d-5a2a3656d686 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4804-01A-11-1739-20 7851ba4e-7820-4d2d-b075-a7f159353aff 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4807 33cf0893-0411-4758-aa90-602bfedf0850 10/31/2012 KIRC Prior malignancy Prior malignancy thyroid cancer. No systemic chemotherapy or radiation.
TCGA-BP-4807-01A-21-1739-20 709b2409-c5bd-4504-9d31-8f0ff8878b74 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4959-01A-21-1739-20 c4e51126-fd56-4831-aa68-3c0e5df56d29 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4960-01A-21-1739-20 3f3e1ccb-d1b4-4d45-93cb-44b64f35a13e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4961-01A-21-1739-20 dccc1e22-1980-4965-b9eb-eb6f2273c15e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4962-01A-21-1739-20 2e39c41f-0ca1-470c-8af4-7a017bc22529 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4963-01A-21-1739-20 6136fa38-252c-4540-b9cb-28539619ac90 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4964-01A-21-1739-20 c33ada60-72ff-4004-a6fe-e33f22750f89 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4965 ec6aa756-c875-49f5-89e4-365b3f18b589 10/31/2012 KIRC Prior malignancy Prior malignancy follicular lymphoma R groin treated with locoregional radiation
TCGA-BP-4965 ec6aa756-c875-49f5-89e4-365b3f18b589 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy follicular lymphoma R groin treated with locoregional radiation
TCGA-BP-4965-01A-21-1739-20 e9bcbff2-35fd-4337-80b0-9c1f5ce35647 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4967-01A-21-1739-20 a96547ac-4ae8-40d4-8914-9adac8591c06 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4968-01A-21-1739-20 3f8789e5-86f5-4238-9e79-94ac74d3fb8a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4969-01A-21-1739-20 8370cff5-689f-4997-b35a-0b445ce4cef7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4970-01A-21-1739-20 85853323-0c71-4746-969c-8b95f4ef1370 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4971-01A-21-1739-20 966f096c-bd20-4acb-93d5-a9a93baa243e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4972-01A-21-1740-20 13f57884-5751-44e3-a427-1e5e3e2c3612 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4973-01A-21-1740-20 7e70879c-ec68-4851-a2ce-3b6cf2ac427c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4974-01A-21-1740-20 2cdc2aad-46f7-4400-9e93-16ca117dab1d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4975-01A-21-1740-20 18271f38-78a1-40ea-8b8c-954ff3d62b93 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4976 2375ef64-8212-4ad4-97e8-bfa6d1db430f 04/02/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4976 2375ef64-8212-4ad4-97e8-bfa6d1db430f 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy colon cancer in unknown location treated w/ locoregional radiation. Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-BP-4976-01A-21-1740-20 329d8f75-dadb-41b0-989e-01f22abfcc5b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4977-01A-21-1740-20 691526ae-c34d-4010-a97e-e531155df5dd 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4981-01A-21-1740-20 985de066-5d35-418f-b34b-e620be2dbf29 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4982-01A-21-1740-20 24527a31-1c21-4c4f-b398-3dd3f01a4522 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4983-01A-21-1740-20 99a02db5-19d0-4c9d-888e-a65bc5a9f8ba 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4985-01A-21-1740-20 043ac5c0-ba86-4e98-9688-d1d241c28d44 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4986 ccd44d97-f0d5-47cd-9c12-af458c750d23 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy R colon cancer treated with systemic chemotherapy.
TCGA-BP-4986 ccd44d97-f0d5-47cd-9c12-af458c750d23 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4986-01A-21-1740-20 5a7e475b-de82-4221-a614-4c71e19f5916 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4987-01A-21-1740-20 fc539d7a-1a7b-40e9-928a-a3b820917b0c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4988 9c8169e7-9193-41f5-878e-ed1af3b95422 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy L lung adenocarcinoma treated with fludarabine and L lung bronchoalveolar cancer. No systemic chemotherapy or radiation.
TCGA-BP-4988 9c8169e7-9193-41f5-878e-ed1af3b95422 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4988-01A-21-1740-20 16f771b8-55aa-490c-b772-f3ec02f6b7ab 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4989-01A-21-1740-20 14b53f6f-6467-47aa-9690-18937c7b078d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4991-01A-21-1740-20 3e9b7386-9ad4-4bac-bccc-756b635839ea 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4992-01A-21-1740-20 47c4ffd0-04a8-4e4d-9261-0873ac2cab45 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4993 6ccd4657-ffa3-4e82-929f-9a7366a89578 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation. Patient with synchronous R KIRC.
TCGA-BP-4993 6ccd4657-ffa3-4e82-929f-9a7366a89578 11/10/2012 KIRC Synchronous malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation. Patient with synchronous R KIRC.
TCGA-BP-4993-01A-03-1739-20 390f12aa-59d1-4876-93ef-086c669d457e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4994 82f069c4-7928-4b7b-8a42-114db7de0501 06/21/2011 KIRC Item in special subset Subsequent to most TCGA analysis, TSS noted that the case may be Chromophobe Renal Cell Carcinoma. Program Office determined this will be a Notification vs. a Redaction
TCGA-BP-4994-01A-21-1740-20 f5e22cc3-5adc-40bb-be12-770904969079 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4995 9245a557-01ea-4446-b9e9-313f6ab18834 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy basil cell carcinoma of the neck with unknown chemotherapy per e-mail.
TCGA-BP-4995 9245a557-01ea-4446-b9e9-313f6ab18834 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4995-01A-21-1740-20 52dcb60f-7583-4ce1-ae95-af019526b8fa 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4998-01A-21-1740-20 bdeb1ff3-1cf5-4560-80e5-713254f3fe78 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4999 9aa63985-16ba-4d43-a6ec-4a35f2ff6513 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy melanoma of the L eye treated with locoregional radiation.
TCGA-BP-4999 9aa63985-16ba-4d43-a6ec-4a35f2ff6513 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4999-01A-21-1740-20 fad769c2-11bf-4a57-ae6c-867aa422267c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5000-01A-21-1740-20 804406fd-a453-491e-8c10-0fdaf4c03f9e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5001-01A-21-1740-20 306667bc-b2b8-4c11-8eab-7a7c35f59d60 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5004-01A-21-1740-20 c7acc221-47e6-4fd9-8a4d-52a6582e790b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5006 b5f51cf6-1013-4d4b-aff1-4b7e8f6afd9c 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy basil cell cancer treated with unknown chemotherapy per e-mail.
TCGA-BP-5006 b5f51cf6-1013-4d4b-aff1-4b7e8f6afd9c 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-5006-01A-21-1740-20 1e27b24a-5e34-4c37-a886-2da9d0824c27 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5007-01A-21-1740-20 6704b452-ac70-40d8-8464-e60fb6756a03 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5008-01A-21-1740-20 d937a49c-f446-4f1c-a36f-4be1a507b327 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5009 57070e5b-0eb5-44b7-abb3-3007fa34543a 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy Hairy Cell Leukemia treated with Interferon.
TCGA-BP-5009 57070e5b-0eb5-44b7-abb3-3007fa34543a 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-5009-01A-21-1740-20 06be1c91-747d-491d-b6ec-1147e5b5201b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5010-01A-03-1739-20 144e8999-4322-457f-aa97-f57af3ffd282 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5168 781acafa-a58b-4180-bbca-c5b675d51b17 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-BP-5168-01A-21-1740-20 87fe49d8-eadf-4604-8330-0e6d8c5d50f7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5169-01A-21-1740-20 5cba849a-e38c-4195-b624-d8d6b69b9d27 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5170-01A-21-1740-20 aa421322-50f9-4099-acbd-9384747a50f4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5173-01A-21-1740-20 db209dff-9608-4f28-88da-a08a45b91140 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5174-01A-21-1740-20 6ac66405-a827-47d0-a0c7-703c9d1f414d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5175-01A-21-1740-20 9f4d47d2-7de4-4926-ad7d-461be7737ba0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5176-01A-21-1740-20 ea856a3f-cf30-4abf-bdcb-fc41b0a5b7b2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5177-01A-21-1740-20 1d5bffc5-6e67-4bc9-9670-707c81f70bf2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5178 6e9e5e05-2bf8-4724-8e31-241f517289de 10/31/2012 KIRC Prior malignancy Prior malignancy chronic lymphocytic leukemia. No systemic chemotherapy or radiation.
TCGA-BP-5178-01A-21-1740-20 6eae97cf-2d1c-4350-8948-d7c4fc011f10 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5180-01A-21-1740-20 a658860b-353e-40e9-ba58-eca96555e989 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5181 5358b8c7-d69c-4485-9420-03416564187b 10/31/2012 KIRC Prior malignancy Prior malignancy L breast cancer treated with Arimidex and locoregional radiation.
TCGA-BP-5181 5358b8c7-d69c-4485-9420-03416564187b 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy L breast cancer treated with Arimidex and locoregional radiation.
TCGA-BP-5181-01A-21-1740-20 43335a0d-b231-4dfb-865a-95ae9108b781 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5182-01A-21-1740-20 ba2a13be-35dd-46c9-84cf-947a3f88a790 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5183-01A-21-1740-20 b5dd7bce-2db2-4d29-b182-f4a1e6f49d11 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5184-01A-21-1740-20 b62cecd6-5408-4c8a-bd3b-cbc8dc39367e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5185-01A-21-1740-20 7199415a-1a03-4b95-899b-06a13be1d44b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5186-01A-21-1740-20 3a1b35fc-f161-4c43-88d2-a0627c14a623 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5187-01A-21-1741-20 09b9a6fa-2080-4ab5-ac93-99babaff9014 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5189 23c7555b-7a37-415d-bda8-3588078a0c2e 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-BP-5189-01A-03-1740-20 5760a312-43d7-42fb-b03d-b2c6728ab74a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5190-01A-21-1741-20 60ae5978-788a-4a5e-9514-745ca6641cda 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5191 b9fc9eff-1228-482d-87a2-ebbb5c92733a 11/10/2012 KIRC Synchronous malignancy Pt with synchronous prostate cancer.
TCGA-BP-5191-01A-21-1741-20 fbb7e113-e460-4038-bb8c-ad92213c8f1e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5192-01A-21-1741-20 2e276db0-a903-46c0-8892-620fc0e94de6 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5194-01A-03-1740-20 9004a9cd-9abe-4d82-b170-1ca87a76a952 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5195-01A-03-1741-20 8f347faf-21d3-447d-9d80-4cab2e44999a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5196-01A-21-1741-20 f2f9fbed-f0e5-46c2-bea5-9e0ec2e46d4b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5198-01A-21-1741-20 374b3c10-d46f-45e0-90f7-a515106650ce 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5199 d30f460b-8e85-4eb4-83b8-0a5d8bf4d10d 04/02/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-5199 d30f460b-8e85-4eb4-83b8-0a5d8bf4d10d 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy L lung cancer with brian mets treated with etoposide and cisplatin and locoregional radiation.
TCGA-BP-5199-01A-21-1741-20 b8cb6f03-8bee-4536-94cd-86064a138c3f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5200-01A-21-1741-20 56c5d2f2-381d-4ab9-ba13-e6fd89334a12 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5201 54c9850c-9b67-42ea-a04b-16a88f786dfa 10/31/2012 KIRC Prior malignancy Prior malignancy melanoma of the chest wall. No systemic chemotherapy or radiation.
TCGA-BP-5201-01A-21-1741-20 79e08f1a-b74e-4a1c-95e3-bd4baced10c3 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5202-01A-03-1741-20 95d23ab2-4aa6-4ebe-a0b1-f7288abca684 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4634-01A-03-1738-20 4e48150c-3cce-4e50-8e66-cf03f7c69056 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4635-01A-03-1738-20 1c764337-0a77-43f3-aff2-59df7b707ac4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4636 2d8da564-e69f-4bfa-a1d3-227a294f3886 02/05/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-CJ-4638-01A-03-1738-20 35666f7d-78a4-45ea-9b97-abf4fe4becf4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4640-01A-03-1738-20 35073bca-d686-4881-b1bb-36fb06254380 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4642 942c0088-c9a0-428c-a879-e16f8c5bfdb8 02/05/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-CJ-4642 942c0088-c9a0-428c-a879-e16f8c5bfdb8 10/29/2010 KIRC Molecular analysis outside specification Molecular results off spec
TCGA-CJ-4642 942c0088-c9a0-428c-a879-e16f8c5bfdb8 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Pt with synchronous B-cell lymphoma treated with cyclophosphamide, Adriamycin, vincristine, prednisone, and Rituxin prior to procurment of TCGA tumor.
TCGA-CJ-4642 942c0088-c9a0-428c-a879-e16f8c5bfdb8 11/10/2012 KIRC Synchronous malignancy Pt with synchronous B-cell lymphoma treated with cyclophosphamide, Adriamycin, vincristine, prednisone, and Rituxin prior to procurment of TCGA tumor.
TCGA-CJ-4642-01B-03-1738-20 c251400a-a330-4bec-9097-be6d3d8081a2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4868-01A-21-1739-20 1009a8c5-1c9e-4077-9d5f-3952c2a7c941 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4869 06d86d68-0fd5-4c6e-8783-ed732a3291e8 02/05/2011 KIRC Neoadjuvant therapy [intgen.org]: Subject Positive for Neo-Adjuvant Therapy
TCGA-CJ-4869 06d86d68-0fd5-4c6e-8783-ed732a3291e8 02/05/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-CJ-4869 06d86d68-0fd5-4c6e-8783-ed732a3291e8 10/31/2012 KIRC Neoadjuvant therapy Prior malignancy and neo-adjuvant therapy per e-mail. (No data in OC.)
TCGA-CJ-4869-01A-03-1739-20 b3abcf18-06f8-4971-8d1f-b8baa42c14fa 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4870-01A-21-1739-20 f8f5806e-287a-4fdf-93cf-4ca9d7affe9c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4871-01A-21-1739-20 773195ed-d001-4b7a-a297-09fab7099a7a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4872-01A-21-1739-20 ef59a075-02f4-4d9b-9cfe-777dcfa43a72 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4873-01A-21-1739-20 711a2ab5-898a-4e61-8544-451d574f6bc2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4874-01A-21-1739-20 8d66085c-74d6-41c6-8830-666d7013063e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4875-01A-21-1739-20 dc38f3cd-505f-49b4-8dea-aeee94fb3f1c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4876-01A-21-1739-20 e216cec1-b30a-4aab-afd4-bc0c1b7b758f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4878-01A-21-1739-20 83c99552-fdd7-4b9c-9bfb-fb8570c44d29 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4881-01A-21-1739-20 1a7f6ad8-97f3-416d-8d1e-1752bb6638f7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4882-01A-03-1739-20 159db16d-5e3e-4bcd-a5a2-07a96ca895f0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4884-01A-21-1739-20 6d50911f-9c1a-4030-b610-89a719b56131 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4885-01A-21-1739-20 fa006edc-8525-4d6e-ba13-e4c134464c4b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4886-01A-21-1739-20 a00ba6f0-2c30-4b10-adeb-73cc069e8445 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4887-01A-21-1739-20 42bf6823-a5cb-4c33-91aa-d70eb018287b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4888-01A-21-1739-20 97252db5-78f5-477c-ac3a-7c092dd94887 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4889-01A-21-1739-20 708465ee-ef9c-40de-ba2f-71514be59146 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4890-01A-21-1739-20 1403b7bb-a3a2-438c-bb7a-7a5fc629b054 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4891 d232f22d-a3e7-41c8-97e1-205de2b488aa 02/05/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-CJ-4891-01A-21-1739-20 e92fbbf1-3320-4b68-b781-fc48afef80da 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4892-01A-21-1739-20 44f82cb9-ef4c-4db4-b422-ebf57eed8923 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4893-01A-21-1739-20 e7a4846e-fc06-4860-9889-1be8a401ef1a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4894 d1e4f4c0-08cc-4012-9372-9ab987d80dab 02/05/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-CJ-4894-01A-21-1739-20 46fefccc-e4e4-4978-94d4-947352fe01a5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4895-01A-21-1739-20 22064330-d7aa-4233-b7a9-cf0af042b915 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4897-01A-04-1739-20 0de5b055-e5c2-476d-acab-28786a73df23 01/09/2012 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4899-01A-21-1739-20 6f832a87-5075-47ec-ba25-548a651a38d0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4900 33cd8b05-2b9b-40dd-97a2-40d02e27ee90 02/05/2011 KIRC Neoadjuvant therapy [intgen.org]: Subject Positive for Neo-Adjuvant Therapy
TCGA-CJ-4900-01A-21-1739-20 8f37e702-a8bc-4cc0-8a4d-2e8fc0097327 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4901-01A-21-1739-20 00f49512-9a51-4cbd-b226-6841f35774c1 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4902-01A-21-1739-20 bd711e1e-b075-4340-bdb1-517235e43f6d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4903-01A-21-1739-20 a694ae1f-4241-4b23-b4be-fc2ed41d84e7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4904 ec3b2a30-fcf6-45ef-bd9d-e6089a237c0f 11/10/2012 KIRC Synchronous malignancy Pt with synchronous carcinoid tumor of the intestine.
TCGA-CJ-4904-01A-03-1739-20 cea8dac4-2528-40b2-bdfb-219410a1ac12 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4905-01A-03-1739-20 9b07060d-54ab-411e-b7da-7ef6109db687 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4907-01A-21-1739-20 49f9282d-b523-4e77-af6e-17d74042f52f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4908-01A-21-1739-20 d63bf325-90ea-4d22-8272-8b0914dbb77a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4912-01A-21-1739-20 7ab6de82-86af-4737-bc64-98787c2b33e2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4913-01A-21-1739-20 0f73a4b3-8966-4cc9-b49b-367aff4a79cf 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4916-01A-21-1739-20 daba7c03-e941-4ff9-9d1a-20b476e9888a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4918-01A-21-1739-20 02e1794a-8cfb-490e-9af8-9dff35683336 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4920-01A-21-1739-20 08e06e35-8e6a-4167-8aa7-e02859c83d42 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4923-01A-21-1739-20 756043d1-cc58-49ef-a948-9b8472ff0d4f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5671-01A-13-1742-20 4b882f59-a669-417e-a5d9-356622a845eb 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5672-01A-13-1742-20 6efde3f2-9c26-48dd-8171-cb66673c5e83 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5675-01A-13-1742-20 b99e86e6-ae17-4281-9948-a8f105237a67 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5676-01A-13-1742-20 a18152a6-b906-493d-bda3-172b72f6549b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5677-01A-13-1742-20 77c4c9d8-a521-439f-9d60-0a09c56a562f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5678-01A-13-1742-20 f67614d8-c450-4aab-b81e-d47f55a6f34d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5679-01A-13-1742-20 70f8b600-310f-48ad-a296-656819936be8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5680-01A-13-1742-20 6ab4c822-53e9-47fa-8aea-09b03c5e58fc 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5681-01A-13-1742-20 7280e1fd-d0cb-4e42-adcf-10b0fcdf72c8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5682-01A-13-1742-20 6ba42350-6550-458d-96c6-c7da867c65f5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5683-01A-13-1742-20 12ef7421-3991-4d0a-95b1-607bcf0da31a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5684-01A-13-1742-20 2055b0c3-576c-4764-b95b-3b6746112eec 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5686-01A-13-1742-20 2b5fc01f-892f-4428-9e60-b66880059c84 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5689 e865d40a-9989-436c-8426-88cc84c863e8 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-CJ-5689 e865d40a-9989-436c-8426-88cc84c863e8 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-CJ-5689-01A-13-1742-20 35cab9c3-34ee-434d-80ed-8ada59b8b930 01/09/2012 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-6027 4467ae73-499a-4af0-8431-e059d6ed21a5 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-CJ-6027 4467ae73-499a-4af0-8431-e059d6ed21a5 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-CJ-6027-01A-13-1742-20 0780aac3-469d-4fd8-82a1-60a6642363ce 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-6028-01A-13-1742-20 2a81c785-8223-442a-9356-6874f9c6d01b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-6030 6ab00314-5228-43ba-9880-9d5177b64c61 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-CJ-6030-01A-13-1742-20 64bab513-27ff-4cc2-b81a-319a0b3f4f48 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-6031-01A-13-1742-20 d40c42ee-633f-4465-ad1c-2aa6ad9039ad 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-6032-01A-13-1742-20 8f17ab9e-1351-49cd-b9b6-36ff8cdb0335 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-6033-01A-13-1741-20 96223115-b21c-488c-a5ea-d7a556d0cf5d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5580-01A-21-1741-20 aa97e126-0b18-44d1-8bdd-f19231ad17ee 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5581-01A-03-1741-20 ef407399-9c48-4179-8fae-db3d525bf435 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5583-01A-03-1741-20 47488fc1-1947-45b6-b7ef-e40cc6a17e0c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5584-01A-21-1741-20 c9976c78-5a6c-4a8f-a7a6-402bdc42f0c8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5585-01A-21-1741-20 6f1e29aa-f291-4583-b810-88bedde78d1f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5587-01A-21-1741-20 5953704f-af25-418c-88a8-658ec08de796 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5588-01A-21-1741-20 55709f9b-4d97-427e-9419-ff26af023ae8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5589-01A-21-1741-20 64d562b1-9f1b-4a0c-aaa2-356a2b6393f0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5590-01A-21-1741-20 828dcf1d-5bdf-45d9-8d92-0967384c1b93 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5591-01A-21-1741-20 fa816bae-50dd-4dbf-9787-24bce5d334e1 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-6087-01A-13-1742-20 21eba48f-71ab-4c94-9d17-db945445d1ec 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-6088-01A-13-1742-20 1b7245a3-c52b-4696-8369-a29eb6987c11 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-6090-01A-13-1742-20 6172753c-54b7-4b29-ba38-9a91eb36617d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-6093-01A-13-1742-20 8120bc77-982c-4fa5-afc8-14bc96ddf4e4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-6096 f6cd140f-e331-41a3-8a6d-b93076458a37 07/17/2014 KIRC Item is noncanonical Incomplete distribution. Only Repli-G and proteomics shipped.
TCGA-CW-6096-01A-13-1742-20 798b2d2e-3c8e-4f11-b048-da3266e5b712 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-6096-11A-01W dfc84859-fe4a-42f2-958b-005b50faf619 10/28/2011 KIRC Molecular analysis outside specification NA
TCGA-CW-6097-01A-13-1742-20 fd03af71-0731-458b-9219-a462a2380dd6 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4853-01A-03-1738-20 1d594413-a926-4446-8354-11ad4a89be5e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4854 2efcefca-5e52-4b3d-a48a-9e9c73cc0141 10/31/2012 KIRC Prior malignancy Prior malignancy bladder cancer. No systemic chemotherapy or radiation.
TCGA-CZ-4854-01A-21-1738-20 8ce7c32e-78c1-40f0-ba8b-2c7e30bba545 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4856 fcecafa8-8b8b-4ae6-81bc-73acf05b211a 10/31/2012 KIRC Prior malignancy Prior malignancy breast cancer treated with locoregional radiation.
TCGA-CZ-4856 fcecafa8-8b8b-4ae6-81bc-73acf05b211a 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy breast cancer treated with locoregional radiation.
TCGA-CZ-4856-01A-03-1738-20 2aff5626-901d-4dd7-881d-7551cf59f121 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4857-01A-21-1738-20 679c1ab6-ec0a-47c6-b0ce-89406ffee17c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4858-01A-21-1738-20 94313271-144a-437b-96da-ffb5d9222c01 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4859-01A-03-1738-20 84bb9422-61e4-4b0e-a3c4-fe82643ea21d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4860-01A-21-1738-20 4234e620-8e3c-4597-8f16-716966f29cbc 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4861 226ce515-c12c-4195-bb5d-d6df2e135ff6 03/13/2011 KIRC Neoadjuvant therapy [intgen.org]: Subject was positive for neo-adjuvant therapy
TCGA-CZ-4861-01A-21-1738-20 c0a6affc-ff68-4146-9d82-3b233a23d6d0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4862 b10eb61b-50b8-4df5-8c46-386a1b58c6a6 10/31/2012 KIRC Prior malignancy Prior malignancy B-cell non-Hodgkins lymphoma of the forehead treated with locoregional radiation.
TCGA-CZ-4862 b10eb61b-50b8-4df5-8c46-386a1b58c6a6 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy B-cell non-Hodgkins lymphoma of the forehead treated with locoregional radiation.
TCGA-CZ-4862-01A-21-1738-20 6121d0d7-6152-4e62-a67f-2956dc74f012 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4863-01A-21-1738-20 28ba39dc-7aa1-451d-92e4-6805031c7784 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4864 7fc6b44d-ae66-409c-98e1-c1a518c33e95 09/26/2014 KIRC Case submitted is found to be a recurrence after submission Patient diagnosed with RCC 3 years prior to procurement of the TCGA specimen and had prior treatment (cryoablation). The TSS did confirm the TCGA tumor was a recurrence.
TCGA-CZ-4864-01A-21-1738-20 abdaba49-f2dd-4487-9cca-c43c421b8155 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4865 305eaef4-4644-46e3-a696-d2e4a972f691 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy Breast treated w/ taxol and radiation.
TCGA-CZ-4865-01A-03-1738-20 f056ed2a-e776-421f-b8c9-2dabbf1fa70d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4866-01A-21-1739-20 68a3141b-8b6d-4b42-85ac-9bed66a1238b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5451-01A-21-1741-20 31f3d889-65ca-484a-ba3b-3fec61a31ac8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5452-01A-21-1741-20 44675867-f3bd-4586-ad16-0ca9ea680107 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5453-01A-21-1741-20 89799ade-6a98-4324-ac18-c3db6912345a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5454-01A-21-1741-20 16ba26a3-58b6-4333-8930-e8fdaed6bb9d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5455-01A-21-1741-20 05f509e8-0e51-4f72-938b-e9a27cc86f5a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5456-01A-21-1741-20 5ec8b366-23c4-4469-9e24-89e2fe1c5af5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5457-01A-21-1741-20 967d6c49-16b4-4dbb-af46-5c4078d34264 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5458-01A-21-1741-20 4e2483c3-bb07-40bd-93f4-98d5773422b7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5459-01B-21-1741-20 f7ad17e2-0024-4664-bc64-9273e9096366 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5460-01A-21-1741-20 efafe88e-ae0d-4833-9448-d8a3c386cb25 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5461-01A-21-1741-20 1448104c-dfa4-4e0d-b825-5fa88572341a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5462-01A-21-1741-20 c9f9aeaf-71ff-4bba-ab6c-38c437b96846 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5463-01A-21-1741-20 1d9d71b3-1d04-442f-bf6d-51c620f2e706 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5464-01A-21-1741-20 1757eaeb-2160-46e1-9678-0ca41855f2bb 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5465-01A-21-1741-20 6dd4f073-00be-474a-bfde-0360719ad6b8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5466-01A-21-1741-20 019da2fa-0b60-4cc0-9a4b-01fff01ea1b8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5467-01A-21-1741-20 bffdb92c-7525-433d-adc8-d71c3b2f7b20 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5468-01A-21-1741-20 220f379b-0963-4686-b7ca-83c22b7ed834 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5469-01A-21-1741-20 81b948b5-c234-4fe8-a747-6b0c40954925 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5470-01A-21-1741-20 379238c9-c4bf-4306-8228-ecaa6cd97a5e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5982-01A-13-1742-20 95c1d092-5e96-4b23-954e-bdf2edb7031d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5984-01A-13-1742-20 3f097427-89ab-40cf-836f-07eec3911d37 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5985-01A-13-1742-20 612e8f1b-394f-4681-a143-469e79f80285 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5986-01A-13-1742-20 cfc2070d-2a8a-4f63-96d2-d0bef349e65e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5987-01A-13-1742-20 edbac373-efd5-4b74-abcf-e0440df89583 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5988-01A-13-1742-20 5144b6fc-2a82-4876-98f7-b9d17c9f8c30 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5989-01A-13-1742-20 e5b38120-7e4b-41b4-a2c4-d4a381ce1f77 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5565 f6d28a1d-6691-4ac1-8afb-ab0e7dcef867 10/31/2012 KIRC Prior malignancy Prior malignancy pancreas cancer. Prior malignancy bilateral kidney cancer x2. No systemic chemotherapy or radiation for any malignancies.
TCGA-DV-5565-01A-21-1741-20 9e9158df-98f6-4f99-b31a-eab2b2ac50ab 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5566 4b2ec8aa-8460-440e-b75b-6b92ae7a3ffc 10/31/2012 KIRC Prior malignancy Prior malignancy pancreas cancer, R KIRC and L kidney cancer. No systemic chemotherapy or radiationfor any malignancies.
TCGA-DV-5566-01A-21-1741-20 1a05c3b4-f1e0-41f5-bcfc-a10a22ddfd58 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5567 aba26e6b-f11c-4ae6-a0d6-85bdd2060e8f 10/31/2012 KIRC Prior malignancy Prior malignancy L KIRC. No systemic chemotherapy or radiation. Patient with synchronous L kidney cancer.
TCGA-DV-5567 aba26e6b-f11c-4ae6-a0d6-85bdd2060e8f 11/10/2012 KIRC Synchronous malignancy Prior malignancy L KIRC. No systemic chemotherapy or radiation. Patient with synchronous L kidney cancer.
TCGA-DV-5567-01A-21-1741-20 21486ff6-8e01-4e31-b553-97b48bf3d8f4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5568 16559faa-8103-4973-a47d-3435443e8ec1 04/21/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-DV-5568 16559faa-8103-4973-a47d-3435443e8ec1 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy L KIRC. No systemic chemotherapy or radiation. Prior malignancy of the eye treated with Avastin. Pt with synchronous bilateral KIRC.
TCGA-DV-5568-01A-21-1741-20 a8d6ad39-cac8-4bfc-84d8-d3dad59c76ab 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5569 fc052a9d-0134-46ce-af98-4703b61d63c4 10/31/2012 KIRC Prior malignancy Prior malignancy bilateral KIRC. No systemic chemotherapy or radiation.
TCGA-DV-5569-01A-21-1741-20 2b5131f9-bdc4-4ac7-a6e1-65b9f927d829 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5573 c6454371-1f84-4e8e-8c3a-2eac8380819e 10/31/2012 KIRC Prior malignancy Prior malignancy pancreas cancer. No systemic chemotherapy or radition. Prior malignancy R KIRC treated with IL-2. Patient with synchronous L KIRC.
TCGA-DV-5573 c6454371-1f84-4e8e-8c3a-2eac8380819e 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy pancreas cancer. No systemic chemotherapy or radition. Prior malignancy R KIRC treated with IL-2. Patient with synchronous L KIRC.
TCGA-DV-5573 c6454371-1f84-4e8e-8c3a-2eac8380819e 11/10/2012 KIRC Synchronous malignancy Prior malignancy pancreas cancer. No systemic chemotherapy or radition. Prior malignancy R KIRC treated with IL-2. Patient with synchronous L KIRC.
TCGA-DV-5573-01A-21-1741-20 dca20655-174a-4714-b5c8-b357aa4cdc34 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5574 ea854858-1dad-4b01-8e58-f19e6a7c41a3 10/31/2012 KIRC Prior malignancy Prior malignancy L KIRC. No systemic chemotherapy or radiation. Patient with synchronous pancreatic cancer.
TCGA-DV-5574 ea854858-1dad-4b01-8e58-f19e6a7c41a3 11/10/2012 KIRC Synchronous malignancy Prior malignancy L KIRC. No systemic chemotherapy or radiation. Patient with synchronous pancreatic cancer.
TCGA-DV-5574-01A-21-1741-20 77e8d72e-3ce3-4acb-895c-b29fb3886e9f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5575 0ff579a1-e295-408d-b194-febbca798e34 11/10/2012 KIRC Synchronous malignancy Pt with synchronous R kidney cancer and pancreatic cancer.
TCGA-DV-5575-01A-21-1741-20 9bdfe4de-c81e-41ec-ad4f-d61a3e2ca2c2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5576 936c217f-f10b-43cf-bb6d-0a74ebec9b13 10/31/2012 KIRC Prior malignancy Prior malignancy R kidney cancer. Prior malignancy L KIRC. No systemic chemotherapy or radiation. Patient with synchronous pancreatic cancer.
TCGA-DV-5576 936c217f-f10b-43cf-bb6d-0a74ebec9b13 11/10/2012 KIRC Synchronous malignancy Prior malignancy R kidney cancer. Prior malignancy L KIRC. No systemic chemotherapy or radiation. Patient with synchronous pancreatic cancer.
TCGA-DV-5576-01A-21-1741-20 8f14a992-965a-4f5a-8289-812ef06db223 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-EU-5904-01A-13-1742-20 54238142-e27f-4285-b762-3a47de6c1af0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-EU-5905-01A-13-1742-20 0984427d-7af1-4ae6-9725-5cf16b05706c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-EU-5906-01A-13-1742-20 4a199575-d30c-416a-b745-bdce432cad1a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-EU-5907-01A-13-1742-20 e43112b9-5cce-495c-9fd7-a51506a1ed01 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-G6-6237 (none) 06/16/2014 KIRC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-G6-6254 (none) 06/16/2014 KIRC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
Made with Nozzle